United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2019_register executive 2019-08-08 article Notices D09002ee1c7d1fd93 D09002ee1c7d1fe4c United States Department of Health and Human Services originator org United States Government Agency or Subagency The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Molecular Targeting Technologies, Inc. (MTTI); a Delaware corporation, with its principle place of business in West Chester, Pennsylvania, to practice the inventions embodied in the patent application listed in the Supplementary Information section of this notice. 84 FR 39001 https://www.govinfo.gov/app/details/FR-2019-08-08/2019-16965 2019-16965 fr08au19-77 4140-01-P https://www.govinfo.gov/app/details/FR-2019-08-08/2019-16965 https://www.govinfo.gov/content/pkg/FR-2019-08-08/html/2019-16965.htm https://www.govinfo.gov/content/pkg/FR-2019-08-08/pdf/2019-16965.pdf 2 p. 39001 39002 84 FR 39001 National Institutes of Health; Federal Register Vol. 84, Issue NOTICE 2019-16965 DEPARTMENT OF HEALTH AND HUMAN SERVICES 2019-08-23 4140-01-P 2019-16965 Notice.

The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Molecular Targeting Technologies, Inc. (MTTI); a Delaware corporation, with its principle place of business in West Chester, Pennsylvania, to practice the inventions embodied in the patent application listed in the Supplementary Information section of this notice.

Only written comments and/or applications for a license which are received by the NHLBI Office of Technology Transfer and Development August 23, 2019 will be considered. Prospective Grant of Exclusive Patent License: Lutetium-177 Radiotherapeutics Against Glioblastoma Multiforme and Small-Cell Lung Carcinoma , shmilovm@mail.nih.gov Vol. 84, no. 153 Office of the Federal Register, National Archives and Records Administration 2019-08-08 continuing daily deposited born digital 335 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2019-08-08 P0b002ee1a2630384 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr08au19 https://www.govinfo.gov/app/details/FR-2019-08-08 https://www.govinfo.gov/content/pkg/FR-2019-08-08/pdf/FR-2019-08-08.pdf https://www.govinfo.gov/content/pkg/FR-2019-08-08/xml/FR-2019-08-08.xml fdlp 38847 39173 DGPO 2019-08-08 2024-05-31 FR-2019-08-08 machine generated eng FR FR-2019-08-08 84 153